Rosie Buckley

Rosie has worked with over 25 life science companies generating and advancing value creation opportunities across multiple indications and therapies, often in novel therapeutics looking for market entry. These evaluations have included market and competitive landscape analysis, technical considerations, a review of the standard of care and upcoming clinical landscape, as well as gap analysis for unmet needs.

Rosemarie Buckley is a strategic consultant with deep experience across 25+ biotech and pharmaceutical organizations, where she has delivered market assessments, portfolio analysis, and market entry strategies. She has supported IPO-stage companies, led pre-IND planning and business development, and contributed to global medical affairs initiatives. Her work spans R&D program analysis, long-range planning reconciliation, and program leadership in a multibillion-dollar merger.

She has also driven five-year growth strategy for a $500M biotech tools business, developed product launch cases, and advised on strategic alliances, operational transformations, and digital health innovation.

Rosemarie Buckley holds an MBA from Stanford University and a BS in Chemical Engineering from the University of Washington. She is a certified Project Management Professional (PMP #19463) and completed a Research Training (Virtual Internship) in Artificial Intelligence in Medicine through the Cambridge Centre for Innovation and Development, deepening her expertise at the intersection of AI and healthcare.